Skip to Content

Analysts have assigned a “Hold” rating to Livent Co. (NYSE:LTHM).

Analysts have assigned a “Hold” rating to Livent Co. (NYSE:LTHM).

According to Bloomberg, the company has been given an average ” Hold ” rating from the fourteen research firms currently covering Livent Co. (NYSE: LTHM). In addition, six market analysts have recommended purchasing the company’s stock, three suggested investors maintain their current holdings, and two suggested that investors liquidate their holdings. The stock currently has a price target of $29.53, the average price target that brokers who graded the stock in the previous year have set for the stock for the next 12 months.
On the subject of the LTHM stock, the opinions of several different research specialists have been presented:
The price target that the company has set for Livent shares, which was previously $26.00, has now increased to $27.00, as stated in a report disseminated on October 4 by Deutsche Bank Aktiengesellschaft.
B. Riley increased their target price on Livent stock and shifted their rating from “neutral” to “overweight” in a report released on Thursday, October 27. The report was about the company’s medical device business.
Vertical Research upgraded their recommendation for the stock of Livent from “hold” to “buy” and set their price objective for the company’s shares at $30.00 in a report on the company’s stock that was made public on Wednesday. Vertical Research’s report was made available to the public.
Piper Jaffray rated Livent as an “overweight” firm in a research report published on Thursday, December 15.
However, in the same report, she decreased their target price for the company’s shares from $42.00 to $38.00. Piper Jaffray’s target price had previously been $42.00. Finally, in a report distributed on Thursday, October 13, Raymond James raised their rating for the stock to “outperform” and increased their price objective from $33.00 to $35.00.
Recently, several hedge funds and other institutional investors have either rebalanced their portfolios to hold less LTHM or reduced the amount of LTHM they previously held. US Bancorp DE increased its holdings in Livent by 46.5 percent over the first three months of 2018. Following the acquisition of a further 6,726 shares during the most recent quarter, US Bancorp DE now holds 21,176 shares of the company’s stock, which have a value of $552,000. This brings the total number of shares owned by the company to 21,176. The number of shares of Livent that Cambridge Investment Research Advisors Inc. owned increased by 27.4% during the first three months of 2018. Cambridge Investment Research Advisors Inc. now owns 20,285 shares of the company’s stock, valued at $529,000, after purchasing an additional 4,359 shares during the most recent fiscal quarter. These shares were purchased for a total of $529,000. Following the acquisition of an additional 6,044 shares in the preceding quarter, HighTower Advisors LLC increased the percentage of Livent stock that it owned during the first quarter by 18.1%. The company now has an ownership interest in 39,483 shares of the company’s stock, which has a value of $1,033,000. The amount of Livent shares that Private Advisor Group LLC owned as of the end of the first quarter was up 3.4% from the beginning of the period. During the most recent reporting period, Private Advisor Group LLC increased its stake in the company by 856 shares, bringing its total number of shares owned to 26,235, with a market value of $684,000. The last and most significant point is that PNC Financial Services Group Inc. increased its holdings in Livent by 7.5% during the first quarter, making it the capstone of this discussion. PNC Financial Services Group Inc. now has 39,016 shares after purchasing an additional 2,726 shares during the most recent period. The stock is currently valued at $1,017,000, and institutional investors own 90.62 percent of PNC Financial Services Group Inc.
On Friday, shares of NYSE: LTHM started trading for $19.55 each. During this period, the all-time low price for Livent was $18.26, while the all-time high price for Livent was $36.38. The current ratio (0.18), the quick ratio (2.65), and the current ratio are all taken into consideration during the calculation of debt to equity (3.52). The moving average for the company over the past 200 days is $27.15, while the moving average over the last 50 days is $25.63. The company’s market capitalization is $3.51 billion, and it has a price-to-earnings ratio of 19.55. Additionally, its beta value is 1.76.
The company’s most recent quarterly earnings report was released on November 1 by Livent (NYSE: LTHM), which can be found here. The company’s earnings per share for the quarter came in at $0.41, which was the same as the estimate compiled by the majority of market participants. The return on equity for Livent came in at 20.00%, while the company’s net margin came in at 26.77%. The revenue the company made during the quarter was $231.60 million, which is lower than the $248.19 million that industry analysts anticipated the company to make during the quarter. Profits at Livent are anticipated to come in at $1.36 per share for the current fiscal year, according to projections made by specialists in the relevant industry.
The Livent Corporation manufactures and distributes high-performance lithium compounds worldwide, including in North America, Latin America, Europe, the Middle East, Africa, and the Asia Pacific. These lithium compounds produce specialized polymers, lithium-ion batteries, and chemical synthesis. The company offers a wide variety of specialty lithium compounds, some of which include high-purity lithium metal, which is used in non-rechargeable batteries and the creation of lightweight materials for aeronautics, as well as lithium compounds for use in high-performance applications, such as battery-grade lithium hydroxide for use in high-performance lithium-ion batteries, butyllithium, which is used in the production of polymers and pharmaceutical products, and other sulfides. The company also provides lithium compounds for Additionally; the company provides a variety of other specialty foods, such as


Leave a comment

Your email address will not be published. Required fields are marked *